Related Experiment Video

Updated: Jun 13, 2025

Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models
07:01

Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models

Published on: May 10, 2022

1.5K

Exosome-mediated renal protection: Halting the progression of fibrosis

Chuanqi Liu1, Qingfeng Li1, Jian-Xing Ma2

  • 1Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, China.

Genes & Diseases
|September 12, 2024
PubMed

Insights

Stem cell-derived exosomes show promise for treating renal fibrosis by reducing inflammation and promoting kidney tissue regeneration. These natural nanoparticles offer advantages over stem cells for treating kidney disease.

Area of Science:

  • Nephrology
  • Regenerative Medicine
  • Nanotechnology

Background:

  • Renal fibrosis, a key factor in chronic kidney disease (CKD), involves inflammation and extracellular matrix deposition, leading to kidney function loss.
  • Current therapies for renal fibrosis offer limited protection, necessitating novel treatment strategies.
  • Stem cell-derived exosomes are emerging as a promising therapeutic approach for renal fibrosis.

Purpose of the Study:

  • To review the therapeutic potential of exosomes, including natural and engineered variants, for treating renal fibrosis.
  • To compare exosome-based therapies with stem cell-based treatments for renal protection and tissue regeneration.
  • To discuss future strategies for enhancing the efficacy of exosome-based therapies in kidney disease.

Main Methods:

  • Review of current literature on exosome biology and their role in intercellular communication.
  • Analysis of studies utilizing exosomes for treating acute kidney injury (AKI) and CKD models.
  • Comparison of exosome therapy advantages (non-immunogenic, low tumor risk, storage ease) against stem cell therapy.

Main Results:

  • Exosomes deliver therapeutic molecules that reduce inflammation, renal fibrosis, and extracellular matrix production in animal models.
  • Exosomes promote tissue regeneration and preserve kidney function in preclinical studies.
  • Exosome-based therapies demonstrate potential advantages in safety and practicality over traditional stem cell treatments.

Conclusions:

  • Exosomes represent a viable cell-free therapeutic strategy for mitigating renal fibrosis and promoting kidney repair.
  • Further research and strategic development are needed to optimize exosome-based therapies for clinical application in kidney diseases.
  • Exosome therapy holds significant promise for improving outcomes in patients with acute kidney injury and chronic kidney disease.
Keywords:
Chronic kidney diseaseExosomesGrowth factorsRenal fibrosisStem cells

More Related Videos

Isolation of Extracellular Vesicles from Murine Bronchoalveolar Lavage Fluid Using an Ultrafiltration Centrifugation Technique09:18

Isolation of Extracellular Vesicles from Murine Bronchoalveolar Lavage Fluid Using an Ultrafiltration Centrifugation Technique

Published on: November 9, 2018

9.5K
Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection10:25

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection

Published on: November 10, 2021

1.8K

Related Concept Videos

Renal Drug Excretion: Tubular Reabsorption01:25

Renal Drug Excretion: Tubular Reabsorption

Tubular reabsorption, a process occurring post-glomerular filtration of drugs in the renal tubule, is a critical determinant of drug half-life. During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. This...
133
Overview of Exosomes01:36

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Drug Elimination by Renal Route: Tubular Reabsorption01:22

Drug Elimination by Renal Route: Tubular Reabsorption

During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. However, the majority of drugs are either weak acids or weak bases, and their ionization level is dependent on pH. By altering the pH of urine, the...
3.3K
Drug Elimination by Renal Route: Glomerular Filtration01:17

Drug Elimination by Renal Route: Glomerular Filtration

The kidney serves as the primary organ responsible for eliminating drugs and their metabolites from the body. This process, known as renal elimination, starts with glomerular filtration and results in urine formation. Each kidney houses millions of functional units called nephrons, where urine production takes place. A nephron has two main components: a renal corpuscle and a renal tubule. Drugs gain access to the kidney via the renal artery, which progressively branches off into afferent...
5.5K